$2.75
00.00%
Pre-Market: Sep 20, 4:20 PM EDT
15 minutes delayed
Harvard Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harvard Bioscience using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $0 | $0.05 | -100.0 % |
Mar 2024 | 2024-05-07 | $0.02 | $0.02 | 0.00 % |
Dec 2023 | 2024-03-07 | $0.04 | $0.05 | -20.0 % |
Sep 2023 | 2023-11-07 | $0.01 | $0.04 | -75.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $23.10M | $26.40M | -12.5 % |
Mar 2024 | 2024-05-07 | $24.51M | $25.79M | -4.96 % |
Dec 2023 | 2024-03-07 | $28.15M | $29.11M | -3.29 % |
Sep 2023 | 2023-11-07 | $25.36M | $28.02M | -9.48 % |
Harvard Bioscience (HBIO) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $0.00, which missed the estimate of $0.05.
The Actual Revenue was $23.1M, which missed the estimate of $26.4M.
Browse earnings estimates, EPS, and revenue on all stocks.